Reasonable markers to track: waist circumference, weight, resting heart rate, sleep quality, and a basic liver panel (ALT, AST) before and after long cycles
Promising results were observed from a phase 1/2 clinical trial of pembrolizumab plus docetaxel, AR inhibitors, or PARP inhibitors in patients with mCRPC
Overweight and obese patients achieved gradual and sustained weight loss without significant side effects
The hormonal imbalances seen in females with PCOS are decreased follicle-stimulating hormone (FSH) and FSH/LH ratio, increase in the level of LH, fasting insulin, estrogen, free testosterone, and a mild increase in prolactin [4]
David E Kelley is now developing the book into a TV series